Manufacturing, Specialty Dosage Forms

Combining Multiparticulates and 3DP for Patient-Centric Dosage Forms

May 03, 2021

Aprecia and Glatt investigate manufacturing technologies to widen the formulation design space for oral delivery.

Nanoform and Aprecia Explore 3D-Printed Drug Dosage Forms

April 21, 2021

The collaboration will evaluate Nanoform’s fast dissolution nanoparticles in Aprecia’s ZipDose 3DP technology platform for buccal and oral drug delivery.

Piramal Pharma Solutions Opens Oral Solid Dosage Drug Product Facility

September 23, 2020

CMDO Piramal Pharma Solutions held a grand opening at a facility they acquired in Sellersville, PA.

Manufacturing Drug–Device Combination Products

September 03, 2020

A device manufacturing process must be carefully designed in the early stages of development to ensure success in commercial manufacturing.

Evonik Commissions US Facility for Bioresorbable Polymers and adds CMO Services

May 19, 2020

Evonik opened a new facility for GMP manufacturing of bioresorbable polymers and excipients for pharmaceutical and medical applications in Birmingham, AL.

Manufacturing Microneedle Array Patches for Vaccine Delivery

May 02, 2020

Equipment and process optimization must be considered for scaling up these developmental technologies to commercial production.

Hovione Technology Begins Pilot-Scale Filling of Blisters for Reusable DPI

November 19, 2019

Hovione Technology worked with Harro Höfliger on powder filling of blisters for the reusable Papillon DPI.

Advancing Transdermal Drug Delivery

November 02, 2019

PATH’s Microarray Patch Center of Excellence aims to accelerate transdermal patch technology for public health needs.

Catalent Invests in Zydis Ultra Commercialization

March 20, 2019

Catalent announces investment for its Zydis ODT technology, offering increased drug load and taste-masking capabilities.

Process Development Best Practices for Topical Drug Products

February 02, 2019

Using a QbD approach in the development and formulation of topical products will enable the drug developer to provide a robust control strategy for manufacturing.